Pharmacological inhibition of Pyk2 reduced basal migration in U87 and HS683 human glioma cells but had little to no effect on A172 human, GL261 mouse, or C6 rat glioma cells suggesting cell line-specific dependencies on Pyk2 signaling. The gene discussed is PTK2B; the disease is central nervous system cancer.